CN Patent

CN101007814A — 吡咯并六元杂环化合物及其在医药上的用途

Assigned to Shanghai Hengrui Pharmaceutical Co Ltd · Expires 2007-08-01 · 19y expired

What this patent protects

本发明涉及通式(I)表示的吡咯并六元杂环化合物或其生理上可接受的盐，其中通式中的取代基如说明书所示，以及含有该衍生物的组合物。本发明还涉及其制法和制备蛋白激酶抑制剂中的用途。

USPTO Abstract

本发明涉及通式(I)表示的吡咯并六元杂环化合物或其生理上可接受的盐，其中通式中的取代基如说明书所示，以及含有该衍生物的组合物。本发明还涉及其制法和制备蛋白激酶抑制剂中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101007814A
Jurisdiction
CN
Classification
—
Expires
2007-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Hengrui Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.